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High glucose stimulates the expression of erythropoietin in
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It has been reported that the levels of erythropoietin are associated with diabetes mellitus. Glomerular
epithelial cells, located in the renal cortex, play an important role in the regulation of kidney function and
hyperglycemia-induced cell loss of glomerular epithelial cells is implicated in the onset of diabetic
nephropathy. This study investigated the effect of high glucose on erythropoietin and erythropoietin
receptor expression in rat glomerular epithelial cells. We found that 25 mM D-glucose, but not mannitol
or L-glucose, stimulated erythropoietin mRNA and protein expression in a time dependent manner (>4 h)
in rat glomerular epithelial cells. In addition, 25 mM glucose, but not mannitol or L-glucose, also
increased the phosphorylation of erythropoietin receptor, suggesting a role for erythropoietin receptor
phosphorylation in erythropoietin synthesis. We conclude that high glucose stimulates erythropoietin
production and erythropoietin receptor phosphorylation in rat glomerular epithelial cells.
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Hyperglycemia has been shown to be a primary factor
in the development of diabetic nephropathy [1]. Glomerular
epithelial cells (GECs), which are located in the renal cortex,
play an important role in the regulation of kidney function,
and hyperglycemia-induced dysfunction of GECs is implicated
in the onset of diabetic nephropathy. In particular, loss of
GECs in diabetic nephropathy is a major factor that induces
the dysfunction of glomerular filtration and eventually induces
albumin and proteinuria [2].
EPO, a 30.4-kDa glycoprotein, is produced mainly by
peritubular fibroblasts of the renal cortex in adult life [3].
In general, erythropoietin (EPO) controls erythropoiesis in bone
marrow through erythropoietin receptor-mediated signaling
pathways [4]. EPO production is generally induced by hypoxic
conditions. However, non-hematopoietic effects of EPO such
as effects on the heart, brain, and kidney have been published
[5-7]. In addition, a recent report suggested that endogenous
EPO production is associated with inflammation and mortality
in diabetic chronic kidney disease [8]. Therefore, we
hypothesized that the expression of EPO and EPO receptor
(EPOR) under diabetic conditions are altered in rat GECs
in vitro. This suggests that an understanding of the patterns
of EPO regulation in the kidney will provide important insights
into processes mediated by diabetic nephropathy. The present
study is aimed at investigating the effect of high glucose on
the expression of EPO and EPOR phosphorylation in rat GECs.
Materials and Methods
Materials
Dulbecco’s Modified Eagle’s Medium (DMEM) and Ham’s
nutrient mixture F-12 (F-12) were purchased from Life
Technologies (Gibco BRL, Grand Island, NY, USA). Fetal bovine
serum (FBS) was purchased from HyClone (Logan, Utah, USA).
D-Glucose was obtained from Sigma Chemical Company (St.
Louis, MO, USA). EPO, phospho-EPOR, and actin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Goat anti-rabbit IgG and rabbit anti-mouse IgG were
Lab Anim Res 2011: 27(3), 245-250
http://dx.doi.org/10.5625/lar.2011.27.3.245
*Corresponding author: Soo Hyun Park, Department of Veterinary Physiology, College of Veterinary Medicine, Chonnam National
University, 300 Yongbong-dong, Buk-gu, Kwangju 500-757, Korea
Tel: +82-62-530-2832; Fax: +82-62-530-2809; E-mail: parksh@chonnam.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.246 Seul Ki Lim, Soo Hyun Park
Lab Anim Res | September, 2011 | Vol. 27, No. 3
purchased from Jackson Immunoresearch (West Grove, PA,
USA). All reagents were of the highest purity commercially
available.
Cell cultures
Rat visceral GECs were isolated and characterized as
described by Kreisberg et al [9]. These cells were used between
passages 10 and 12. The culture medium for glomerular
epithelial cells was DMEM/Ham’s F-12 (1:1) supplemented
with 10% FBS. Glomerular epithelial cells were grown to
confluence in 60 mm dishes in DMEM/Ham’s F-12 (DMEM,
Gibco BRL, Grand Island, NY, USA; F-12 Nutrient Mixture,
Gibco; obtained without glucose and then supplemented by
adding glucose to the appropriate concentrations) with 15
mM HEPES buffer, 10% FBS, 5.5 mM glucose, 0.35% additional
sodium bicarbonate, 2.5 mM L-glutamine, and 1% penicillin/
streptomycin at 37
oC. The cells were maintained at 37
oC
in 5% CO2 in a humidified cell culture incubator. The media
was changed every other day. Passaged cells were plated
to yield near-confluent cultures at the end of the experiments.
These cultured cells exhibit the markers of podocytes. Podocin
and WT1 that are podocyte specific markers were strongly
expressed in cultured podocytes, but not in mesangial cells
(Figures 1A and 1B).
RNA isolation and reverse transcriptase-polymerase
chain reaction (RT-PCR)
Total RNA was extracted from the cells using TRIzol, which
is a monophasic solution of phenol and guanidine
isothiocyanate and which was purchased from Invitrogen
(Carlsbad, CA, USA). Reverse transcription was carried out
with 1 µg RNA using a reverse transcription system kit
(AccuPower
® RT Premix, Seoul, Korea) with oligo-dT18 primers.
Then the RT products (1 µL) were amplified with a PCR kit
(AccuPower
® PCR Premix). The primers used were 5'-
CCTCTGGGCCTCCCAGTCCT-3' (sense) & 5'-CCTCCCCTGT
GTACAGCTTC-3' (antisense) for EPO, 5'-GATAGGTGTCCAG
GCAGGGT-3' (antisense) for podocin, 5'-CCACCTCCAGTGTA
TGGCTG-3' (sense) & 5'-GGGTACGCACACATGAAAGG-3'
(antisense) for WT-1, and 5'-GTACAGTTGTTGGCGAGCA-
3' (sense) & 5'-TGCATCAGAAGTAAGCCTCTC-3' (antisense)
for β-actin. They were used as a control to confirm the quantity
of RNA. The RT-PCR products were separated and visualized
on 1.2% agarose gels. The PCR products were analyzed by
calculating the ratio of the high glucose treatment group relative
to the control group, and standardizing the data relative to
β-actin.
Western blotting
The reactions were stopped by quick freezing in a dry
ice bath. The medium was then removed and the cells were
washed twice with ice-cold phosphate buffered saline (PBS),
scraped, and then harvested by microcentrifugation (3,000
rpm for 10 min) and removal of the supernatant. The pellet
was resuspended in lysis buffer (20mM HEPES, 10% glycerol,
0.5% Triton X-100). The resuspended cells were lysed
mechanically on ice by vortexing. The lysates were centrifuged
at 15,000 rpm for 10 min at 4
oC. The supernatants were
whole cell fractions. The protein level was quantified using
the Bradford procedure. Whole cells (50 µg of protein) were
separated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to an enhanced
nitrocellulose membrane. The blots were then washed with
TBST (10 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.05% Tween-
20), blocked with 5% skim milk (made from a powder) in
TBST for 1 h and incubated for 2 h at room temperature
with the primary antibody at the dilutions recommended
by the supplier. The membrane was then washed with TBST,
and the secondary antibodies conjugated to horseradish
peroxidase were incubated for 2 h at room temperature. The
bands were visualized using Amersham ECL
TMWestern Blotting
Detection Reagents (GE Healthcare, UK) on X-ray film (Kodak
BioMax Light Film; Kodak, Tokyo, Japan). To confirm equal
amounts of protein loaded for each sample, blots were
subsequently stripped using a low pH-buffer containing 1
M glycine, pH 2.0 and 1% SDS and then reprobed with
an antibody that specifically recognized β-actin in the
membranes first treated. The protein in each sample was
quantified as described previously [10].
Figure 1. Expression of rat podocyte specific markers in
cultured glomerular epithelial cells (P) and mesangial cells (M).
Podocytes and mesangial cells were cultured without any
agents. Podocin and WT1 mRNA (A) expression were
analyzed by RT-PCR, and the expression level of Podocin and
WT1 protein (B) were determined by immunoblotting analysis.High glucose regulates EPO expression 247
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Statistical analysis
Results were expressed as mean±SE. All experiments were
analyzed by analysis of variance (ANOVA). In some
experiments, a comparison of treatment means to control
was done using the Bonferroni-Dunn test. A P value <0.05
was considered significant.
Results
Time and dose dependent effects of high glucose on the
expression of EPO mRNA and protein content in rat GECs
The time dependent effects of high glucose on EPO mRNA
and protein content were determined by exposing rat GECs
to 25 mM glucose for various times (0 to 12 h). Glucose
(25 mM) significantly upregulated EPO mRNA levels over a
4-h period; the maximum stimulatory effect was observed
between 4 and 8 h (Figure 2A). We also examined the effect
of high glucose on protein levels of EPO. As shown in Figure
2B, 25 mM glucose significantly upregulated the expression
of EPO protein levels, which correlated with EPO mRNA
expression. In addition, high glucose stimulated the secretion
of EPO in a time dependent manner (>8 h) by analyzing
the media using TCA precipitation (Figure 2C). The dose
dependent effect of high glucose on the expression of EPO
mRNA and protein content was also determined. As shown
in Figure 3A, above 15 mM D-glucose there was an increase
in EPO protein expression. High glucose concentrations can
result in altered medium osmolarity. To rule out an influence
of altered osmolarity on glucose uptake, we tested the effects
of mannitol and L-glucose. Although 25 mM D-glucose
upregulated the expression of EPO protein, 25 mM mannitol
and  L-glucose did not (Figure 3B).
The effect of high glucose on the phosphorylation
of EPO receptors in rat GECs
We investigated the effect of high glucose on EPOR
expression. Glucose (25 mM) significantly stimulated the
phosphorylation of EPOR over a 4-h period (Figure 4). These
results suggest that endogenous EPO secretion induced by
high glucose activates EPOR in rat GECs. To rule out an
influence of altered osmolarity on glucose uptake, we also
tested the effect of mannitol or L-glucose. Although 25 mM
D-glucose stimulated the phosphorylation of EPOR, 25 mM
mannitol and L-glucose did not (Figure 4B).
Discussion
This study demonstrated that high glucose stimulates EPO
secretion in rat GECs. Until now, it has been reported that
EPO expression was restricted to the peritubular cells of the
kidney. However, recently, several lines of evidence have
shown that EPO synthesis is evident in diverse cells such
as astrocytes and hepatocytes [11,12]. In kidney, the evidence
that proximal tubule cell and glomerular epithelial cells
produce EPO protein was reported, although the major sites
of EPO production are peritubular cells of the renal cortex
[13,14]. Those reports are in accordance with our results.
It is generally accepted that EPO secretion is induced by
Figure 2. Time-dependent effect of high glucose on
erythropoietin (EPO) mRNA (A), EPO protein (B), and secreted
EPO protein (C) in rat glomerular epithelial cells (GECs). GECs
were incubated with 25 mM glucose for different time intervals
(1-12 h). EPO mRNA expression was analyzed by RT-PCR.
Secreted proteins were precipitated from the culture medium
with TCA, and the expression level of EPO protein was
determined by immunoblotting analysis. Values are mean ±SE
of three independent experiments with triplicate dishes.
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hypoxia. Our study suggests that EPO is secreted from rat
GECs in the presence of extracellular factors such as
hyperglycemia.
In our study, high glucose stimulated EPO mRNA and protein
expression and secretion in rat GECs. These stimulatory effects
are D-glucose-specific and unlikely due to an osmotic effect
since the responses were not mimicked by mannitol or L-
glucose. The stimulatory effect on EPO expression is
contradictory to reports from clinical studies that plasma EPO
is often low in diabetic patients with anemia and without
anemia [15,16]. Several lines of evidence indicate that
treatment with EPO protects against high glucose-induced
dysfunction of pancreatic beta cells and renal tubular cells
[17,18]. Therefore, we surmised that the levels of endogenously
secreted EPO in response to high glucose contribute to early
protection against diabetic nephropathy and the depletion
of EPO protective role can aggravate the development of
diabetic nephropathy. Our results are in agreement with an
in vivo report that increases in EPO secretion during diabetic
pregnancies may be responsible for the body’s early
endogenous protective mechanisms against diabetic
complications [19]. The action of EPO is mediated by activation
of the EPO receptor [5]. Our study also reported that high
glucose stimulates phosphorylation of the EPOR in rat GECs
(Figure 4). Rat GECs also retain erythropoietin receptor mRNA
and protein [20]. Furthermore, in this study, the pattern of
Figure 4. Time-dependent and osmotic effects of high glucose
on the phosphorylation of erythropoietin (EPO) receptors in rat
glomerular epithelial cells (GECs). GECs were incubated with
25 mM glucose for different time intervals (1-12 h) (A). The
level of EPO receptor phosphorylation was determined by
immunoblotting analysis. Osmotic effects of D-glucose,
mannitol, and L-glucose on EPO phosphorylation (B). GECs
were incubated with D-glucose, mannitol, or L-glucose (25 mM
or 50 mM) for 8 h. Values are mean±SE of three independent
experiments with triplicate dishes. *P<0.05 vs control.
Figure 3. Dose-dependent and osmotic effects of glucose on
erythropoietin (EPO) expression in glomerular epithelial cells
(GECs). GECs were incubated with different doses of glucose
(0 to 50 mM glucose) for 8 h (A). Osmotic effects of D-glucose,
mannitol, and L-glucose on EPO production (B). GECs were
incubated with D-glucose, mannitol, or L-glucose (25 mM or 50
mM) for 8 h. Values are mean±SE of three independent
experiments with triplicate dishes. *P<0.05 vs control.High glucose regulates EPO expression 249
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EPO protein expression in response to high glucose correlated
with EPOR phosphorylation. These results suggest that
stimulation of EPO secretion by high glucose activates EPO
receptors in rat GECs. We firstly demonstrated that high glucose
alone stimulates EPOR phosphorylation. The protective effects
of the endogenous EPO-EPOR system were observed in non-
hematopoietic cells [21,22]. A recent study reported a similar
finding, that exposure of cells to EPOR activator evoked
protective effects against non-ischemic diabetic kidney injury
[23]. Here we provide evidence that endogenous EPO-EPOR
coupling protects against diabetic nephropathy in its early
stages. Whether stimulation of EPO production under
hyperglycemic conditions in this study has clinical implications
is not certain but a protective effect against diabetic
nephropathy may be elicited. Further studies are required
to understand which signaling molecules are involved in the
effect of high glucose. In conclusion, we demonstrated that
high glucose stimulates EPO expression and secretion and
EPOR phosphorylation in rat GECs. These effects may be
associated with early protection against renal damage in
diabetic nephropathy.
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